OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Anti-Infective Therapy is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	131
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	111
Challenges in preserving antibiotic effectiveness: time for a novel approach	87
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	55
Neonatal ocular prophylaxis in the United States: is it still necessary?	51
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	51
Visceral leishmaniasis elimination in India: progress and the road ahead	47
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	47
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	41
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	39
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	34
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	34
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	34
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	34
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	31
Reemergence of monkeypox: prevention and management	31
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	31
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	30
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	29
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	28
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	27
Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?	26
Treatment of vaginitis caused by non-albicans Candida species	26

Identifying predictors of treatment failure with community-acquired pneumonia: an update